Strategic collaboration between Bioneer A/S & National Biologics Facility
Bioneer A/S announces a strategic collaboration with the National [...]
Rare Disease training course: Pluripotent stem cells for rare disease research: banking, data, application, October 25-27, 2021
Bioneer is happy to announce that we will be [...]
“Signal Transduction at the Blood-Brain Barriers”, Virtual symposium, September 22-24, 2021
Bioneer is delighted to participate to the 23rd Symposium [...]
Bioneer & COVID-19 projects, collaboration with UNION therapeutics
Bioneer supports companies in their quest to help COVID-19 [...]
SelectScience webinar, A new era of RNA detection, June 28, 2021
Bioneer is delighted to be a part of SelectScience [...]
ISSCR 2021 – The Global Stem Cell Event Virtual, June 21, 2021
Bioneer is looking forward to participating to the ISSCR [...]
Latest scientific publications
Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease
Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an [...]
Development of a fully human assay combining NGN2-inducible neurons co-cultured with iPSC-derived astrocytes amenable for electrophysiological studies
Development of a fully human assay combining NGN2-inducible neurons [...]
Detection of lncRNA by LNA-Based In Situ Hybridization in Paraffin-Embedded Cancer Cell Spheroids
Detection of lncRNA by LNA-Based In Situ Hybridization in [...]
Monocyte Infiltration and Differentiation in 3D Multicellular Spheroid Cancer Models
Monocyte Infiltration and Differentiation in 3D Multicellular Spheroid Cancer [...]
Efficacy of a novel antimicrobial hydrogel for eradication of Staphylococcus epidermidis, Staphylococcus aureus and Cutibacterium acnes from preformed biofilm and treatment performance in an in vivo MRSA wound model
Efficacy of a novel antimicrobial hydrogel for eradication of [...]
